Diagonal Bio AB
Develops a point-of-care system for rapid pathogen detection in veterinary medicine.
DIABIO | ST
Overview
Corporate Details
- ISIN(s):
- SE0015961826
- LEI:
- 9845000469E56665DD98
- Country:
- Sweden
- Address:
- Medicon Village, Scheeletorget 1, 223 81 Lund
- Website:
- https://diagonalbio.com/
- Sector:
- Manufacturing
Description
Diagonal Bio AB is a biotechnology company that develops diagnostic technologies. The company's core product is the Panviral platform, a point-of-care system designed for the rapid and accurate detection of genetic markers from pathogens such as viruses, bacteria, and fungi. The technology enables on-site sample analysis, providing results in under 15 minutes. A key feature of the platform is its patented method that allows for the exceptionally fast development of new tests. The company's initial focus is on the veterinary market, offering diagnostic solutions for common viruses in horses and other animals.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Diagonal Bio AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Diagonal Bio AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Diagonal Bio AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
